Conversely, MTV and TLG of the primary tumor were lower in Luminal-B and HER2-positive patients who obtained a pCR, suggesting that the primary tumor volume could be a key factor in this subgroup of BC patients undergoing NAC. Here, ERBB2 is linked to breast cancer.